Curaleaf has become the first company to register standardized THC- and CBD-dominant cannabis preparations in Spain under the country's new medicinal cannabis law, Royal Decree 903/2025. This approval by Spain's Agency of Medicines and Medical Devices allows Curaleaf to supply these pharmaceutical-grade cannabis products to hospital pharmacies for medical prescriptions. The milestone highlights Curaleaf's leadership and long-term investment in Spain, where it operates an EU-GMP certified facility. The preparations are expected to become available to patients as Spain's regulated system develops further.
The Software Defined Vehicle (SDV) market is projected to expand from USD 447.55 billion in 2026 to USD 1,707.36 billion by 2035, growing at a compound annual growth rate (CAGR) of 16.0%. This growth is driven by the automotive industry's shift towar...
Popsicle has launched a summer-long Flavor Feud, separating its Cherry, Orange, and Grape ice pop flavors into competing teams led by celebrity captains. Fans are invited to choose their favorite flavor by purchasing solo packs and supporting their t...
Bonaventure has started construction on Attain at Newtown, a $85.3 million, 320-unit Class A multifamily development in Norfolk, Virginia, located in a federally designated Qualified Opportunity Zone. The project, financed through a partnership with ...
Egoist Machines, backed by Y Combinator, has launched AI Passport, a secure system allowing users to store and manage their personal data and preferences across various AI assistants like ChatGPT and Claude. This tool addresses concerns about data pr...
Bavarian Nordic's partner Eurofarma has submitted an application to Brazil's health authority Anvisa for approval of the chikungunya vaccine CHIKV VLP, targeting prevention in people aged 12 and above. This marks a key step in making the vaccine avai...
